Solbar Ningbo Protein Technology (SH:603231)2026-01-23 09:50Financial Projections - The company expects a net profit attributable to shareholders for 2025 to be between 178 million to 191 million CNY, an increase of 56.82 million to 69.82 million CNY compared to the previous year, representing a year-on-year growth of 46.89% to 57.62%[3] - The projected net profit after deducting non-recurring gains and losses for 2025 is estimated to be between 171 million to 182 million CNY, an increase of 61.41 million to 72.41 million CNY compared to the previous year, indicating a year-on-year growth of 56.03% to 66.07%[5] - In 2024, the company's total profit was 144.08 million CNY, with a net profit attributable to shareholders of 121.18 million CNY, and a net profit after deducting non-recurring gains and losses of 109.59 million CNY[6] - There are no significant uncertainties affecting the accuracy of this earnings forecast[8] - The financial data provided is preliminary and has not been audited, with the final figures to be disclosed in the official 2025 annual report[9] Cost Management and Efficiency - The company achieved significant results in cost reduction and efficiency enhancement through a focus on high-end manufacturing, energy optimization, and lean management[7] - The management team effectively reduced procurement costs for non-GMO soybeans by closely monitoring market trends and seizing purchasing opportunities[7]